ketoconazole has been researched along with casopitant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, LM; Apseloff, G; Blum, RA; Gainer, SD; Johnson, BM; Kirby, LC; Lebowitz, PF; Morrison, RA; Schutz, RA; Zhang, K | 1 |
1 trial(s) available for ketoconazole and casopitant
Article | Year |
---|---|
Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist.
Topics: Adolescent; Adult; Antiemetics; Area Under Curve; Cytochrome P-450 CYP3A Inhibitors; Electrocardiography; Enzyme Induction; Humans; Ketoconazole; Middle Aged; Neurokinin-1 Receptor Antagonists; Piperazines; Piperidines; Rifampin; Young Adult | 2010 |